• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期支架血栓形成:几近消失,但永难忘记。

Early stent thrombosis: Nearly gone, but never forgotten.

作者信息

Seto Arnold H, Kern Morton J

机构信息

Division of Cardiology, Department of Medicine, Veterans Affairs Long Beach Healthcare System, Long Beach, California.

出版信息

Catheter Cardiovasc Interv. 2018 Apr 1;91(5):849-850. doi: 10.1002/ccd.27605.

DOI:10.1002/ccd.27605
PMID:29634861
Abstract

Early stent thrombosis occurs in ∼1% of patients treated with primary PCI and increases shock, stroke, and mortality. Early stent thrombosis was associated with small stent diameter, failure to use glycoprotein inhibitors, and bivalirudin use. Minimizing stent thrombosis may require the use of imaging and aggressive antithrombotic therapy.

摘要

早期支架血栓形成发生在接受直接经皮冠状动脉介入治疗(PCI)的患者中的比例约为1%,并会增加休克、中风和死亡率。早期支架血栓形成与支架直径小、未使用糖蛋白抑制剂以及使用比伐卢定有关。尽量减少支架血栓形成可能需要使用影像学检查和积极的抗栓治疗。

相似文献

1
Early stent thrombosis: Nearly gone, but never forgotten.早期支架血栓形成:几近消失,但永难忘记。
Catheter Cardiovasc Interv. 2018 Apr 1;91(5):849-850. doi: 10.1002/ccd.27605.
2
Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention: Novel Insights From an Updated Meta-Analysis.延长高剂量比伐卢定输注可减少接受直接经皮冠状动脉介入治疗患者的大出血且不增加支架内血栓形成:一项更新的荟萃分析的新见解
J Am Heart Assoc. 2016 Jul 22;5(7):e003515. doi: 10.1161/JAHA.116.003515.
3
Low real-world early stent thrombosis rates in ST-elevation myocardial infarction patients and the use of bivalirudin, heparin alone or glycoprotein IIb/IIIa inhibitor treatment: A nationwide Swedish registry report.ST段抬高型心肌梗死患者的低实际早期支架内血栓形成率以及比伐卢定、单独使用肝素或糖蛋白IIb/IIIa抑制剂治疗的应用:一项瑞典全国性登记报告。
Am Heart J. 2016 Jun;176:78-82. doi: 10.1016/j.ahj.2016.02.018. Epub 2016 Mar 12.
4
Effect of postprocedural full-dose infusion of bivalirudin on acute stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcomes in a large real-world population.ST段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗后,术后全剂量输注比伐卢定对急性支架内血栓形成的影响:来自大量真实世界人群的结果
Cardiovasc Ther. 2017 Jun;35(3). doi: 10.1111/1755-5922.12251.
5
Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.急性心肌梗死后经皮冠状动脉介入治疗后支架血栓形成的频率及预测因素。
Circulation. 2011 Apr 26;123(16):1745-56. doi: 10.1161/CIRCULATIONAHA.110.981688. Epub 2011 Apr 11.
6
Early Stent Thrombosis and Mortality After Primary Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction: A Patient-Level Analysis of 2 Randomized Trials.ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后早期支架血栓形成与死亡率:2 项随机临床试验的患者水平分析。
Circ Cardiovasc Interv. 2016 May;9(5):e003272. doi: 10.1161/CIRCINTERVENTIONS.115.003272.
7
Current incidence and clinical outcomes of bivalirudin administration among patients undergoing primary coronary intervention for stent thrombosis elevation acute myocardial infarction.在因支架内血栓形成抬高型急性心肌梗死接受直接冠状动脉介入治疗的患者中使用比伐卢定的当前发生率及临床结果。
Coron Artery Dis. 2007 Mar;18(2):141-8. doi: 10.1097/MCA.0b013e328010a4b2.
8
Bivalirudin in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: outcomes in a large real-world population.替罗非班在急性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗中的应用:一项大型真实世界人群的结局研究。
EuroIntervention. 2013 May 20;9(1):118-24. doi: 10.4244/EIJV9I1A17.
9
Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials.比伐卢定与肝素联合或不联合糖蛋白 IIb/IIIa 抑制剂用于行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者:来自 HORIZONS-AMI 和 EUROMAX 试验的汇总患者水平分析。
J Am Coll Cardiol. 2015 Jan 6;65(1):27-38. doi: 10.1016/j.jacc.2014.10.029.
10
Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial.ST段抬高型心肌梗死直接经皮冠状动脉介入治疗后再梗死的发生率、预测因素及影响:急性心肌梗死血管重建和支架置入的协调结果试验
Circ Cardiovasc Interv. 2014 Aug;7(4):543-51. doi: 10.1161/CIRCINTERVENTIONS.114.001360. Epub 2014 Jun 17.

引用本文的文献

1
Effects of empowerment education on patients after percutaneous coronary intervention: A meta-analysis and systematic review.赋能教育对经皮冠状动脉介入治疗患者的影响:Meta 分析和系统评价。
Medicine (Baltimore). 2023 Jun 9;102(23):e33992. doi: 10.1097/MD.0000000000033992.
2
Clopidogrel Loading Dose 300 vs. 600 mg in Patients Undergoing One-Stop Hybrid Coronary Revascularization: A Prospective Single-Center Randomized Pilot Study.一站式杂交冠状动脉血运重建患者中氯吡格雷负荷剂量300毫克与600毫克的比较:一项前瞻性单中心随机试验研究
Front Surg. 2021 Oct 15;8:768860. doi: 10.3389/fsurg.2021.768860. eCollection 2021.
3
Stent thrombosis in acute coronary syndromes: Patient-related factors and operator-related factors.
急性冠脉综合征中的支架血栓形成:患者相关因素和术者相关因素。
Anatol J Cardiol. 2020 Oct;24(4):274-279. doi: 10.14744/AnatolJCardiol.2020.69679.